Low NT-proBNP levels can rule out ventricular dysfunction in patients with CHD

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Cardiovascular Medicine | 2007年 / 4卷 / 7期
关键词：
D O I：
10.1038/ncpcardio0898
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：350 / 350
相关论文
共 50 条
  • [31] NT-proBNP is superior to BNP in the detection of left ventricular systolic dysfunction in the community
    Costello-Boerrigter, LC
    Redfield, MM
    Rodeheffer, RJ
    Urban, LH
    Mahoney, DW
    Boerrigter, G
    Jacobsen, SJ
    Bailey, KR
    Heublein, DM
    Burnett, JC
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S44 - S44
  • [32] A comparison of BNP and NT-proBNP as markers of mild forms of left ventricular dysfunction
    Hammerer-Lercher, A
    Ludwig, W
    Müller, S
    Neubauer, E
    Puschendorf, B
    Pachinger, O
    Mair, J
    EUROPEAN HEART JOURNAL, 2002, 23 : 570 - 570
  • [33] Nt-ProBNP: A surrogate marker of left ventricular hypertrophy and diastolic dysfunction in hypertension?
    Mouly, C
    Lantelme, P
    Rial, MO
    Legedz, L
    Champomier, P
    Vincent, M
    Milon, H
    JOURNAL OF HYPERTENSION, 2005, 23 : S193 - S194
  • [34] ProBNP, BNP, and NT-proBNP circulating levels are altered by hemodiafiltration but still correlate with ventricular function in chronic hemodialysis patients
    Bargnoux, Anne-Sophie
    Klouche, Kada
    Fareh, Jeannette
    Barazer, Isabelle
    Dupuy, Anne-Marie
    Leray-Moragues, Helene
    Villard-Saussine, Sylvie
    Giuliani, Isabelle
    Cristol, Jean-Paul
    Canaud, Bernard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 315 - 315
  • [35] Monitoring of BNP, NT-proBNP and xylosyltransferase I levels in patients with ventricular assist device support
    Götting, C
    Schöttler, M
    Prante, C
    Müller, S
    Schön, S
    Brinkmann, T
    Milting, H
    El Banayosy, A
    Körfer, R
    Kuhn, J
    Kleesiek, K
    CLINICAL CHEMISTRY, 2004, 50 (06) : A25 - A25
  • [36] NT-proBNP as a marker for ruling out preeclampsia
    Nan, M. N.
    Garrido-Gimenez, C.
    Mora, J.
    Ullmo, J.
    Garcia-Manau, P.
    Sanchez-Garcia, O.
    Garcia-Osuna, A.
    Cruz Lemini, M.
    Llurba, E.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54
  • [37] NT-proBNP Levels in Myeloma Patients Without Evidence of Amyloidosis
    Zojer, N.
    Strasser-Weippl, K.
    Schreder, M.
    Hubl, W.
    Ludwig, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S142 - S143
  • [38] Variability of NT-ProBNP levels in patients with stable heart failure
    Araujo, J. P.
    Azevedo, A.
    Lourenco, P.
    Ferreira, A.
    Goncalves, F. Rocha
    Bettencourt, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 208 - 209
  • [39] Prognostic significance of NT-proBNP levels in patients treated with empagliflozin
    Durak, Beyza Algul
    Durak, Musa Ilker
    Ata, Naim
    Ulgu, Mahir
    Birinci, Suayip
    CLINICAL NEPHROLOGY, 2025, 103 (03) : 225 - 231
  • [40] Patients with left ventricular dysfunction in clinical practice: NT-proBNP predicts mortality in men as well as in women
    Kilkowski, A.
    Keller, G.
    Muth, K.
    Hochadel, M.
    Zugck, C.
    Remppis, A.
    Senges, J.
    Winkler, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 208 - 208
12345